Pharmacy

Since the FDA first warned that ranitidine products may contain a potentially cancer-causing impurity, known as N-nitrosodimethylamine, numerous drugmakers have recalled their ranitidine products and some consumers have sued. 

Precision Dose, a South Beloit, Ill.-based prescription drug supplier, is recalling five lots of its ranitidine oral solution after finding a potential human carcinogen. 

Controlling drug costs has become a top issue for voters and candidates in the 2020 election. Democrats have argued President Donald Trump has done little to address the issue, despite it being one of his campaign promises in 2016.

Vizient signed an agreement Nov. 21 with German drugmaker Fresenius Kabi to supply six critical care drugs through its Novaplus pharmacy program. 

An Orlando, Fla.-based patient assistance charity agreed Nov. 20 to pay $4 million to settle allegations it helped three drugmakers pay kickbacks to Medicare patients taking multiple sclerosis drugs.

The FDA Nov. 20 approved Alnylam's drug, Givlaari, which comes with a $575,000 price tag, as the first treatment for a rare genetic disorder. 

Louisville, Ky.-based Jewish Hospital & St. Mary's Healthcare will pay $10.1 million to settle claims that its in-house pharmacy knowingly submitted false claims to Medicare for drugs that didn't meet coverage requirements, the U.S. Justice Department said. 

Sen. John Thune, R-S.D.,  one of the top Republicans in the Senate, said that it's "unlikely" the Senate will pass legislation to lower drug prices before the end of the year, according to The Hill.

Eli Lilly said Nov. 20 it plans to invest $400 million to expand its Lilly Technology Center in Indianapolis and add 100 jobs for technicians, scientists and engineers.

Amgen will cut 172 more jobs across the country, including some from its headquarters in Thousand Oaks, Calif., according to Endpoints News.